Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company

Refine Search
Americas
Law firm Schiff Hardin has added Cindy Ahn as counsel in its intellectual property practice group.   2 April 2015
Americas
There are important differences between the EPO and the USPTO in the assessment of patentable subject matter in life sciences. Depending on the technology involved, patentees may elect national or regional applications as a useful alternative to PCT filings, as Joachim Wachenfeld and Oswin Ridderbusch explain.   2 April 2015
Americas
Forest Labs, a subsidiary of Actavis, has sued InvaGen for allegedly infringing four patents covering depression drug Viibryd, in what is the fifth related lawsuit.   1 April 2015
Americas
A US appeals court has overturned a district court's decision to deny Apotex's request for a declaratory judgment that its proposed generic blood pressure drug would not infringe a patent owned by pharmaceutical company Daiichi Sankyo.   1 April 2015
Asia
The Indian government is “seriously considering” extending the term of data exclusivity protection for agrochemical inventions from three to five years, it has been claimed.   1 April 2015
Americas
Purdue Pharma has sued Collegium Pharmaceutical for allegedly infringing four of its patents relating to extended release painkiller OxyContin.   1 April 2015
Americas
The US Food and Drug Administration has denied Amgen’s petition asking that the so-called patent dance between a biosimilar maker and the product’s innovator be a mandatory requirement.   30 March 2015
Biotechnology
An appeals board at the European Patent Office has said that any patent applications covering a “product-by-process” method for developing plants can be granted.   27 March 2015
Biotechnology
Some of the parties involved in the landmark patent case Biogen v Medeva met in London in February to discuss the dispute in front of an invited audience. Here is an overview of their memories and the lessons they learned.   25 March 2015
Americas
Cancer treatment company Helsinn and pharmaceutical company Roche have sued Hospira for allegedly infringing five patents covering intravenous anti-nausea drug Aloxi.   25 March 2015